A Phase 1 Study of Cytokine-induced Memory-like NK Cells in Patients With Relapsed and Refractory AML
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lymphokine-activated killer cells (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 21 May 2021 Biomarkers information updated
- 28 Aug 2013 New trial record